Daily ShareChat: Abano Healthcare
By Jenny Ruth
Abano Healthcare's first-half results show the company's underlying businesses have been hurt by the tough economic conditions but the results are still "surprisingly robust," given the vulnerablilty of many of the businesses to discretionary spending, says McDouall Stuart.
Excluding the $76.6 million net proceeds from the New Zealand Bay Audiology sale, the net profit was $3.4 million, down from $4.1 million last year, although the latest result includes only a five-month contribution from the sold business.
Operating profit fell slightly by 2%, implying that margins have tightened over the last six months and that breaks Abano's record of improving operating profit every year since 2006, the broker says.
The audiology sale has left the company with no New Zealand debt and a gearing ration of 15% relating to Australian dental debt after the company returned 52 cents per share to shareholders and an under-subscribed buyback. (The buyback was under-subscribed by $28.6 million with only $17.3 million taken up.)
Abano is in a strong position to continue its growth strategy through both greenfield investment and acquisition, McDouall Stuart says.
Its remaining businesses are less mature and lower margin but present better growth opportunities. "We continue to see Abano as a solidly managed company with excellent growth prospects."
BROKER CALL: McDouall Stuart rate Abano Healthcare as buy.
Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.
Related News
Daily ShareChat: Abano Healthcare Abano first-half profit soars on asset sale proceeds Bay Audiology sells NZ arm Daily ShareChat: Abano Healthcare Abano shares leap on sale of NZ audiology business Daily ShareChat: Abano Healthcare Stonking profit for Abano Healthcare
NZX Annoucements for ABA
|
Abano Healthcare Group Limited Ordinary Shares
Current quote:
ABA $5.45
Quotes delayed 20 minutes
Price when article published: $5.78
Previous News
Sharemarket News By Email
Stock Quote
At a Glance
| NZX 50 Index |
3223.45 |
 |
2.70 |
| S&P/ASX 200 |
4814.20 |
 |
5.80 |
| Dow Jones Industrials |
10567.30 |
 |
3.00 |
Comment & Analysis
|
“
Firstly me – on the 9th of February I received a call from the Endocrinology Department of Waikato Hospital asking how long it would take me to get to their clinic – when I hesitated to think, the specialist said “I mean today!” I turned up at the hospital to find the Doc himself standing [...]
”
Wayne Lochore More »
|
|
|